These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 19808545)
121. Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo. von Lukowicz T; Silacci M; Wyss MT; Trachsel E; Lohmann C; Buck A; Lüscher TF; Neri D; Matter CM J Nucl Med; 2007 Apr; 48(4):582-7. PubMed ID: 17401095 [TBL] [Abstract][Full Text] [Related]
122. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac. Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970 [TBL] [Abstract][Full Text] [Related]
124. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses. Sevillano N; Girón MD; Salido M; Vargas AM; Vilches J; Salto R J Biochem; 2009 Jan; 145(1):21-30. PubMed ID: 18849572 [TBL] [Abstract][Full Text] [Related]
125. Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro. Yoshida T; Park JS; Yokosuka K; Jimbo K; Yamada K; Sato K; Takeuchi M; Yamagishi S; Nagata K Spine (Phila Pa 1976); 2009 Jul; 34(15):1544-8. PubMed ID: 19564763 [TBL] [Abstract][Full Text] [Related]
126. Production of anti-epithelial antibodies and acantholysis by vaccination with an anti-idiotypic antibody, mimicking desmoglein 1. Avalos-Díaz E; López-Robles E; Alvarado-Flores E; Herrera-Esparza R Exp Dermatol; 2008 Jan; 17(1):44-8. PubMed ID: 18095944 [TBL] [Abstract][Full Text] [Related]
127. Polymeric particles conjugated with a ligand to VCAM-1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis. Deosarkar SP; Malgor R; Fu J; Kohn LD; Hanes J; Goetz DJ Biotechnol Bioeng; 2008 Oct; 101(2):400-7. PubMed ID: 18428114 [TBL] [Abstract][Full Text] [Related]
128. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays. Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221 [TBL] [Abstract][Full Text] [Related]
129. [Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts]. Huang KH; Liu JH; Zhu ZH; Li XX; Lu XP; Zhou SY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1137-40. PubMed ID: 17715009 [TBL] [Abstract][Full Text] [Related]
130. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis. Susa Y; Masuda Y; Imaizumi H; Namiki A Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040 [TBL] [Abstract][Full Text] [Related]
131. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro. Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780 [TBL] [Abstract][Full Text] [Related]
132. Single-step purification of pepsin-derived monoclonal antibody fragments from crude murine ascitic fluids by ceramic hydroxyapatite high-performance liquid chromatography. Moro A; Yoshitake T; Ogawa T; Ichimura T J Biochem; 2008 Dec; 144(6):733-9. PubMed ID: 18835826 [TBL] [Abstract][Full Text] [Related]
133. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(-/-) mice. Hoving S; Heeneman S; Gijbels MJ; te Poele JA; Russell NS; Daemen MJ; Stewart FA Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):848-57. PubMed ID: 18514779 [TBL] [Abstract][Full Text] [Related]
135. In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE). Monteiro FA; Cardoso I; Sousa MM; Saraiva MJ FEBS Lett; 2006 Jun; 580(14):3451-6. PubMed ID: 16716307 [TBL] [Abstract][Full Text] [Related]
136. Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli. Kumano-Kuramochi M; Xie Q; Sakakibara Y; Niimi S; Sekizawa K; Komba S; Machida S J Biochem; 2008 Feb; 143(2):229-36. PubMed ID: 18032414 [TBL] [Abstract][Full Text] [Related]
137. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820 [TBL] [Abstract][Full Text] [Related]
138. [The immunoreactivity of IgG and its fragments from ITP patients and their effects on platelet aggregation function]. Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Wang L; Zhang F; Ma DX Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):158-61. PubMed ID: 16792915 [TBL] [Abstract][Full Text] [Related]
139. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. Park K; Hong HY; Moon HJ; Lee BH; Kim IS; Kwon IC; Rhee K J Control Release; 2008 Jun; 128(3):217-23. PubMed ID: 18457896 [TBL] [Abstract][Full Text] [Related]